BCM
ARAV

BlueCrest Capital Management’s Aravive, Inc. Common Stock ARAV Stock Holding History

BlueCrest Capital Management’s Portfolio ARAV Stock Details ARAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-7,024
Closed -$59K – 1509
2018
Q3 		$59K Buy
7,024
+1,990
+40% +$21K ﹤0.01% 1430
2018
Q2 		$61K Buy
+5,034
New +$51.8K ﹤0.01% 1423

Other funds holding ARAV

NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NTC
NF Trinity Capital Central, Hong Kong $626M AUM 3.16% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BlueCrest Capital Management's ARAV Position: Q4 2018 in Review

BlueCrest Capital Management sold out of Aravive, Inc. Common Stock (ARAV) in Q4 2018, closing a stake of 7,024 shares — an estimated $59K sold.

BlueCrest Capital Management first reported a position in ARAV in Q2 2018 and held it in 2 quarters. The position peaked at $61K in Q2 2018. 38 funds tracked by Wall St. Rank hold ARAV as of Q4 2018.

  • BlueCrest Capital Management reported no remaining Aravive, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • BlueCrest Capital Management sold 7,024 Aravive, Inc. Common Stock shares in Q4 2018, an estimated $59K.
  • BlueCrest Capital Management first reported a position in Aravive, Inc. Common Stock in Q2 2018 and held it in 2 quarters.
  • BlueCrest Capital Management's Aravive, Inc. Common Stock position peaked at $61K in Q2 2018.
  • 38 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q4 2018.

Based on BlueCrest Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.